PCN71 A COMPARISON OF THE COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR PREVENTING SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES FROM PROSTATE CANCER IN 4 EUROPEAN COUNTRIES
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)71966-0
https://www.valueinhealthjournal.com/article/S1098-3015(11)71966-0/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
124
First Page :
A264
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71966-0&doi=10.1016/S1098-3015(11)71966-0